相关实验视频
Updated: Jul 1, 2025

10:36
Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
19.4K
基于生理学的药理动力学建模和Cefotaxime在早产和终产新生儿中的剂量优化
Qiaoxi Li1, Yanping Guan2, Chen Xia1
1Department of pharmacy, the first people's hospital of Foshan, Foshan, China.
Journal of pharmaceutical sciences
|March 9, 2024
概括
这项研究开发了一种基于生理学的药理动力学 (PBPK) 模型,用于新生儿的塞福塔克西姆. 该模型根据产后和妊娠年龄优化了早产和满期新生儿的塞福他西姆剂量方案.
科学领域:
- 药理动力学和药物新陈代谢
- 儿科药理学 儿科药理学
- 计算生物学 计算生物学
背景情况:
- 塞福塔克西姆是新生儿细菌感染的关键抗生素.
- 对新生儿进行准确的药理动力学表征对于有效治疗至关重要.
- 现有的剂量计划可能需要针对不同新生儿群体进行优化.
研究的目的:
- 开发和验证新生儿Cefotaxime的生理学基础的药理动力学 (PBPK) 模型.
- 评估和提出针对新生儿的优化赛福他西姆剂量方案.
- 为了利用PBPK建模,在儿科患者群体中精确剂量.
主要方法:
- 使用PK-SIM®软件构建了一个全身PBPK模型.
- 纳入肝脏新陈代谢,膜过和活跃的管状分泌.
- 应用了与年龄相关的药物动力学变化的本体信息,并与临床数据进行了验证.
主要成果:
- PBPK模型准确地描述了成人Cefotaxime的药理动力学,并成功扩展到新生儿.
- 模型在成人和新生儿群体中表现出良好的预测性能.
- 根据产后年龄 (PNA) 和妊娠年龄 (GA) 提出了最佳的塞福他西姆剂量,区分了早产和满产新生儿.
结论:
- 开发的PBPK模型为新生儿的塞福他西姆剂量提供了一个有价值的工具.
- 根据PBPK建模的精确剂量策略,可以提高治疗疗效.
- 这种方法为儿科中基于PBPK模型的精确剂量提供了宝贵的经验.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
71
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
71
Pharmacokinetic Models: Overview
682
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
682
Model Approaches for Pharmacokinetic Data: Physiological Models
44
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
44
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
39
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
39
Physiological Pharmacokinetic Models: Assumption with Protein Binding
44
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
44

